A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus by Ilson David H, Kelsen David, Shah Manish, Schwartz Gary, Levine Douglas A, Boyd Jeff, Capanu Marinela, Miron Benjamin, Klimstra David in Cancer (2011).

[PMID: 21425140] PubMed


Discussed In Paper


Dosing Information

No dosing information annotated.